CLINICAL_TRIALS
trial_result
· 2019-08-28
Clinical Trial Update: SCD-Haplo: Phase II Study of HLA-Haploidentical SCT for Aggressive SCD [Phase 2]
Summary
Phase II study of HLA-haploidentical stem cell transplantation for aggressive sickle cell disease was terminated; results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Damiano Rondelli, MD | Conditions: Sickle Cell Disease | Phase 2 | Status: TERMINATED | Results posted: 2019-08-28